Effect of Omentectomy on Metabolic Syndrome, Acute Phase Reactants & Inflammatory Mediators in Patients Undergoing LRYGBP: A Randomized Trial
Although weight loss controls Metabolic Syndrome and reduces the level of inflammatory
markers in patients with Morbid Obesity, patients may enjoy the benefit achieving metabolic
control before significant weight loss occurs.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Components of Metabolic Syndrome (Body Mass Index)
Basal
Yes
Miguel F Herrrera, MD, PhD
Principal Investigator
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico: Ethics Committee
INCMNSZ-1486
NCT00923260
December 2005
July 2008
Name | Location |
---|